Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sweet Capital is a private venture capital investment fund founded by the creators of King.com after its acquisition by Activision Blizzard. Based in London with offices in Los Angeles and Stockholm, it invests exclusively its own capital into early-stage technology-driven consumer startups across the US and Europe. It is not a life science/biotech/pharma/healthcare company nor does it have any drug pipeline or clinical programs—it operates solely as an investor within the broader tech sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sweet Capital.